Behavioral Therapy for OAB & UUI
Behavioral therapy is the default first treatment for idiopathic overactive bladder (OAB) and urgency urinary incontinence (UUI). The 2024 AUA/SUFU OAB guideline states that clinicians should offer behavioral therapies to all patients with OAB, and should also discuss containment and skin-protection strategies for patients with UUI.[1] The appeal is practical: behavioral treatment is low risk, inexpensive, compatible with pharmacotherapy or procedures, and often targets triggers that drugs do not fix.
This page is the behavioral-treatment companion to the OAB & UUI treatment database, Pelvic Floor Physical Therapy, anticholinergic / antimuscarinic agents, and β3-adrenergic receptor agonists.
Practice Guideline Position
The AUA/SUFU guideline separates behavioral therapy from broader non-invasive therapies:[1]
| Category | Examples | Practical interpretation |
|---|---|---|
| Behavioral therapies | Bladder training, fluid management, caffeine reduction, physical activity / exercise, dietary modification, mindfulness | Offer to all patients; excellent safety; success depends on acceptance, coaching, and adherence |
| Select non-invasive therapies | Pelvic floor muscle therapy, transcutaneous tibial nerve stimulation, transvaginal electrical stimulation, yoga | May offer; safety is favorable, but efficacy and evidence certainty vary by modality |
| UUI management strategies | Pads, briefs, barrier creams, skin care, bedside commode / urinal access | Discuss with all patients with leakage; these improve dignity and skin safety but are not disease-modifying |
Bladder training has the strongest evidence base within the behavioral bundle.[1][2] PFMT overlaps with behavioral care when the goal is urge suppression and learned detrusor inhibition, but it is best treated as a formal pelvic-floor intervention when tone, strength, coordination, or pain phenotyping is needed.
Components
Behavioral therapy is an umbrella, not a single handout.[2][3][4]
| Component | How it is delivered | Clinic target |
|---|---|---|
| Bladder training / bladder drill | Education, fixed voiding interval, diary review, gradual interval lengthening, positive reinforcement | Reach 3-4 hours between voids without panic urgency |
| Scheduled voiding / timed voiding | Voids occur by clock rather than urgency | Frailty, cognitive impairment, caregiver-dependent toileting, high-volume urgency |
| Urge suppression | Stop moving, sit or stand still, relax abdomen / thighs / jaw, use rapid pelvic-floor contractions if appropriate, breathe, distract, then walk calmly once urgency fades | Break the urgency-rushing-leak loop |
| Fluid management | Avoid large boluses; distribute intake; reduce evening fluid when nocturia is diary-linked | Reduce frequency without causing dehydration |
| Caffeine / alcohol / dietary trigger trial | Time-limited elimination and rechallenge based on diary | Identify patient-specific urgency triggers |
| Constipation management | Stool softening strategy, fiber / osmotic laxative when needed, defecatory mechanics | Reduce rectal loading and pelvic-floor guarding |
| Weight loss and activity | Structured program when BMI is elevated; realistic exercise prescription | Reduce incontinence burden and improve mobility |
| Mindfulness / CBT-informed strategies | Urgency exposure, attention shifting, catastrophizing reduction, coping skills | Reduce fear-driven urgency amplification |
Bladder Training Protocol
A practical bladder-training prescription:
- Start with a 3-day bladder diary to identify the shortest safe interval.
- Set the initial voiding interval just below the usual urgency interval.
- Void by the clock while awake; avoid "just in case" voiding outside the plan.
- When urgency arrives early, use urge suppression until the scheduled time.
- Increase the interval by about 15 minutes after several successful days.
- Continue for 8-12 weeks, aiming for 3-4 hour intervals.[2]
This works best when the patient can see progress in diary data: fewer urgency episodes, fewer leaks, longer intervals, and fewer panic bathroom trips.
Urge Suppression Script
Teach the patient a short script:
- Stop: do not rush to the toilet.
- Still: sit or stand quietly; rushing intensifies detrusor contraction and leakage risk.
- Soften: relax abdomen, gluteals, thighs, shoulders, and jaw.
- Squeeze only if appropriate: use several quick pelvic-floor contractions when the patient can contract without pain or guarding.
- Shift attention: slow breathing, counting backward, or another distraction until the urgency wave falls.
- Walk calmly: go to the bathroom after the urge recedes.
For patients with pelvic-floor tenderness, pain, or guarding, route to Pelvic Floor Physical Therapy; repeated strengthening can worsen a high-tone phenotype.
Evidence Snapshot
Behavioral therapy vs. oxybutynin
The foundational Burgio randomized trial in older women with urge incontinence compared biofeedback-assisted behavioral training, oxybutynin, and placebo. Behavioral therapy produced an 80.7% reduction in incontinence episodes, compared with 68.5% with oxybutynin and 39.4% with placebo; behavioral therapy was statistically superior to drug therapy.[6][7]
A urodynamic companion analysis showed behavioral training reduced incontinence frequency by 82.3%, oxybutynin by 78.3%, and placebo by 51.5%. Oxybutynin increased cystometric capacity, while behavioral therapy increased the volume at strong desire to void, consistent with learned urgency tolerance rather than simple detrusor paralysis.[6]
Systematic reviews
| Evidence source | Key finding |
|---|---|
| Balk 2019 network meta-analysis | For urgency UI, behavioral therapy was significantly more effective than anticholinergics for cure or improvement, with high strength of evidence[8] |
| Cochrane bladder training 2023 | Bladder training may be more effective than anticholinergics for curing or improving OAB symptoms and may be safer; certainty was low to very low[2] |
| Cochrane conservative-interventions overview 2022 | PFMT with feedback / biofeedback, electrical stimulation, and bladder training all improved symptomatic cure or improvement vs control; anticholinergics plus behavioral intervention were probably more effective than anticholinergics alone[9] |
Combining Behavioral and Drug Therapy
Behavioral therapy can be used as the first step, as a combination partner, or as a rescue strategy when medications are stopped because of adverse effects.
| Population | Trial signal | Practical takeaway |
|---|---|---|
| Women: tolterodine + supervised behavioral modification | More patients achieved at least 70% reduction in incontinence with combination therapy than with drug alone (69% vs. 58%)[5] | Combination can help when drug response is incomplete |
| Women: optimized oxybutynin ± behavioral therapy | Adding concurrent behavioral therapy did not significantly improve outcomes beyond individualized drug therapy and side-effect management[10] | Optimized pharmacotherapy narrows the additive margin |
| Men: behavioral vs drug vs combination | At 6 weeks, combined therapy reduced voiding frequency more than drug therapy alone, but not more than behavioral therapy alone[4] | A stepped strategy beginning with behavioral therapy alone is reasonable |
Medication partners are covered in anticholinergic / antimuscarinic agents, β3-adrenergic receptor agonists, and the OAB & UUI treatment database.
CBT, Mindfulness, and Weight Loss
Structured cognitive behavioral therapy (CBT) is an emerging OAB adjunct. A systematic review found high-level evidence for improvement in symptom severity and moderate evidence for quality-of-life, psychological, and satisfaction outcomes, while objective clinical signs remained less consistent.[11] A 2024 randomized trial of a multicomponent intervention incorporating CBT principles and exposure-based bladder training improved disease-specific quality of life in women with moderate-to-severe OAB, with good feasibility and minimal side effects.[12]
Weight loss is one of the strongest lifestyle interventions when obesity contributes to incontinence. In a randomized trial of 338 overweight or obese women, a structured weight-loss program reduced mean incontinence episodes by 47%, compared with 28% with education alone.[5]
Patient Selection and Delivery
Behavioral therapy is broadly appropriate, but the delivery model should match the patient:
| Patient pattern | Best delivery model |
|---|---|
| Motivated, cognitively intact, mild-moderate OAB | Diary-guided bladder training with nurse / clinician follow-up |
| OAB with pelvic pain, dyspareunia, guarding, constipation, or poor muscle awareness | Pelvic health PT; avoid strengthening-first instructions until phenotype is known |
| Frailty, dementia, limited mobility, caregiver-dependent toileting | Timed voiding, prompted voiding, bedside commode access, clothing simplification, skin care |
| Heavy caffeine / evening fluid / edema-driven nocturia | Diary-driven trigger correction and nocturnal polyuria workup |
| Mixed UI | Pair bladder training and urge suppression with SUI-directed PFMT or SUI procedural counseling |
Adherence is the limiting factor. Build follow-up around reviewable data: diary intervals, leak counts, urgency scores, pad use, fluid timing, stool pattern, and patient-defined goals.
Operative and Clinic Pearls
- Offer behavioral therapy even when procedural treatment is likely; it improves baseline control and gives patients a non-drug rescue skill.
- Do not label every pelvic-floor intervention "Kegels"; urge suppression, relaxation, and coordination may matter more than strengthening.
- Use a bladder diary to avoid treating nocturnal polyuria, polydipsia, or edema as refractory OAB.
- In UUI, discuss pads, barrier creams, and skin care early; containment is quality-of-life care, not therapeutic failure.
- If symptoms worsen during bladder training, check PVR, UTI, constipation, pain, and whether the starting interval was too ambitious.
References
1. Cameron AP, Chung DE, Dielubanza EJ, et al. "The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder." J Urol. 2024;212(1):11-20. doi:10.1097/JU.0000000000003985
2. Funada S, Yoshioka T, Luo Y, et al. "Bladder Training for Treating Overactive Bladder in Adults." Cochrane Database Syst Rev. 2023;10:CD013571. doi:10.1002/14651858.CD013571.pub2
3. Goode PS, Burgio KL, Richter HE, Markland AD. "Incontinence in Older Women." JAMA. 2010;303(21):2172-2181. doi:10.1001/jama.2010.749
4. Burgio KL, Kraus SR, Johnson TM, et al. "Effectiveness of Combined Behavioral and Drug Therapy for Overactive Bladder Symptoms in Men: A Randomized Clinical Trial." JAMA Intern Med. 2020;180(3):411-419. doi:10.1001/jamainternmed.2019.6398
5. Lukacz ES, Santiago-Lastra Y, Albo ME, Brubaker L. "Urinary Incontinence in Women: A Review." JAMA. 2017;318(16):1592-1604. doi:10.1001/jama.2017.12137
6. Goode PS, Burgio KL, Locher JL, et al. "Urodynamic Changes Associated With Behavioral and Drug Treatment of Urge Incontinence in Older Women." J Am Geriatr Soc. 2002;50(5):808-816. doi:10.1046/j.1532-5415.2002.50204.x
7. Burgio KL, Locher JL, Goode PS, et al. "Behavioral vs Drug Treatment for Urge Urinary Incontinence in Older Women: A Randomized Controlled Trial." JAMA. 1998;280(23):1995-2000. doi:10.1001/jama.280.23.1995
8. Balk EM, Rofeberg VN, Adam GP, et al. "Pharmacologic and Nonpharmacologic Treatments for Urinary Incontinence in Women: A Systematic Review and Network Meta-analysis of Clinical Outcomes." Ann Intern Med. 2019;170(7):465-479. doi:10.7326/M18-3227
9. Todhunter-Brown A, Hazelton C, Campbell P, et al. "Conservative Interventions for Treating Urinary Incontinence in Women: An Overview of Cochrane Systematic Reviews." Cochrane Database Syst Rev. 2022;9:CD012337. doi:10.1002/14651858.CD012337.pub2
10. Burgio KL, Goode PS, Richter HE, et al. "Combined Behavioral and Individualized Drug Therapy Versus Individualized Drug Therapy Alone for Urge Urinary Incontinence in Women." J Urol. 2010;184(2):598-603. doi:10.1016/j.juro.2010.03.141
11. Steenstrup B, Lopes F, Cornu JN, Gilliaux M. "Cognitive-behavioral Therapy and Urge Urinary Incontinence in Women. A Systematic Review." Int Urogynecol J. 2022;33(5):1091-1101. doi:10.1007/s00192-021-04989-3
12. Funada S, Luo Y, Uozumi R, et al. "Multicomponent Intervention for Overactive Bladder in Women: A Randomized Clinical Trial." JAMA Netw Open. 2024;7(3):e241784. doi:10.1001/jamanetworkopen.2024.1784